Longeveron Inc. (LGVN) vs Lunai Bioworks Inc. (LNAI)

Longeveron Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Longeveron Inc. and Lunai Bioworks Inc. are of similar size ($9.1M and $8.8M). Lunai Bioworks Inc. has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (0.00% vs −4,549.0%). Across the 12 metrics below, Longeveron Inc. leads on 6 and Lunai Bioworks Inc. on 6.

Valuation

Metric LGVN LNAI Biotechnology median
P/E n/m n/m 7.88
P/S 7.43 n/m 11.47
P/B 0.85 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.09 n/m 10.73
Earnings yield (352.31%) (3,132.07%) (28.84%)
Free cash flow yield (236.36%) (86.80%) (23.03%)

Profitability

Metric LGVN LNAI Biotechnology median
Gross margin 69.76% 0.00% 65.16%
Operating margin (1,992.84%) 0.00% 0.00%
Net margin (1,977.59%) 0.00% 0.00%
Free cash flow margin (1,755.69%) 0.00% 0.00%
Return on equity (203.61%) (325.46%) (57.72%)
Return on assets (145.64%) (201.09%) (49.22%)
Return on invested capital (4,549.04%) 0.00% 0.00%

Growth

Metric LGVN LNAI Biotechnology median
Revenue growth (TTM) (42.74%) — 5.64%
EPS growth (last fiscal year) 50.76% (28.38%) —
Revenue growth, 5-year CAGR (26.60%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LGVN LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.63 0.19 4.73
Net debt to EBITDA 0.20 0.03 0.96

Dividend

Metric LGVN LNAI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LGVN LNAI Biotechnology median
Market cap 9.12m 8.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack